Seegene, Inc., a leading developer of multiplex PCR technologies, has announced the publication of its Multiple Detection Temperatures (MuDT) technology in Scientific Reports, the open-access journal from the publishers ofNature.
The MuDT technology is a next-generation qPCR technology that allows simultaneous detection and quantification of multiple targets in a single fluorescence channel, without melting curve analysis after amplification. According to Seegene representatives, MuDT technology provides a powerful and cost-effective path to upgrading any real-time PCR instrument, doubling its multiplexing capacity without any changes in the number of channels used.
“Seegene expends tremendous effort to continually develop and commercialize innovative PCR chemistry technologies that improve clinical molecular diagnostics. We are very pleased by the resulting academic and commercial adoption of technologies and products,” says Jong-Yoon Chun, PhD, founder and CEO of Seegene.
Dr. Chun continues, “Our recently announced supply agreement with Beckman Coulter, new U.S. patent for Tagging Oligonucleotide Cleavage & Extension (TOCE) technology, and this publication of MuDT technology are all meaningful milestones ahead of Seegene's planned entry into the U.S. market and potential partnerships with leading in-vitrodiagnostics players.”
In November, Seegene also unveiled the first of three comprehensive Allplex assays, a 26-target Respiratory Panel. This panel will be followed by a 26-target Gastrointestinal Infection Panel and a 27-target Sexually Transmitted Infection Panel in early 2015. Seegene will continue to expand its Allplex family of infectious disease panel tests, and aims to receive CE Mark on the first three assays in 2015.
Read the article about MuDT on the Nature website
